Ignite Creation Date:
2024-05-06 @ 3:01 PM
Last Modification Date:
2024-10-26 @ 1:41 PM
Study NCT ID:
NCT04494425
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-07-12
First Post:
2020-07-20
Brief Title:
Study of Trastuzumab Deruxtecan T-DXd vs Investigators Choice Chemotherapy in HER2-low Hormone Receptor Positive Metastatic Breast Cancer
Sponsor:
AstraZeneca
Organization:
AstraZeneca